Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1998
08/20/1998WO1998035941A1 New benzolactam derivatives and medicinal compositions containing the same
08/20/1998WO1998035937A1 Cetp activity inhibitors
08/20/1998WO1998035704A1 Targeted therapeutic delivery of vitamin d compounds
08/20/1998WO1998035695A1 Wound healing
08/20/1998WO1998035689A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998WO1998035688A1 Method for destroying retinal pigment epithelial cells
08/20/1998WO1998035682A1 Agent for hormonal contraception and/or treatment and/or prophylaxis of mammary glands with three hormone components
08/20/1998WO1998035675A1 Method of using neurotrophic sulfonamide compounds
08/20/1998WO1998035671A1 Remedies for parkinsonism
08/20/1998WO1998035663A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998WO1998020146A3 Stabilized transient gene expression
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998WO1998014215A3 Glycoconjugates as virus cell adhesion inhibitors
08/20/1998DE19712659C1 Use of Alchemilla vulgaris extract as angiogenesis inhibitor
08/20/1998DE19705963A1 Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung Networked vinyl polymers with bile acid Adsorberwirkung
08/20/1998DE19705718A1 Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände New oxiranecarboxylic for the treatment of type 2 diabetes and other insulin-resistant states
08/20/1998DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids
08/20/1998CA2281690A1 Method for destroying retinal pigment epithelial cells
08/20/1998CA2281607A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998CA2281602A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998CA2281086A1 Oligomers which inhibit expression of collagen genes
08/20/1998CA2281033A1 The proliferation of cell-inhibiting peptide and its use
08/20/1998CA2280968A1 Secreted proteins and polynucleotides encoding them
08/20/1998CA2280896A1 Novel human mago nashi protein
08/20/1998CA2280742A1 Method of using neurotrophic sulfonamide compounds
08/20/1998CA2280700A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998CA2280634A1 Human p24 vesicle proteins
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998CA2279838A1 Receptor that binds trail
08/20/1998CA2279590A1 Targeted therapeutic delivery of vitamin d compounds
08/20/1998CA2278757A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
08/20/1998CA2278746A1 4-aminoethoxyindazole derivatives
08/20/1998CA2278700A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2251368A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/19/1998EP0859054A1 Drug binding protein
08/19/1998EP0859000A1 Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof
08/19/1998EP0858999A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
08/19/1998EP0858807A2 Use of dopamine receptor antagonists in palliative tumor therapy
08/19/1998EP0858467A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
08/19/1998EP0858461A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors
08/19/1998EP0858459A1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
08/19/1998EP0858444A1 Cyclopentyl tachykinin receptor antagonists
08/19/1998EP0858443A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858442A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858345A1 Use of muteins of wild-type cytokines as immunogens
08/19/1998EP0858341A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin
08/19/1998EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
08/19/1998EP0858335A1 2-alkylpyrrolidines
08/19/1998EP0858333A1 Thiamorphinans with neuroprotective activity
08/19/1998EP0767783B1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists
08/19/1998EP0660936B1 Up-converting reporters for biological and other assays using laser excitation techniques
08/19/1998EP0643068B1 Erythromycin derivative
08/19/1998CN1190963A 2-amino-benzoxanones for the treatment of viral infections
08/19/1998CN1190957A Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino) carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998CN1190955A Crystalline £R-(R',R')|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl|-1H-pyrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998CN1190890A Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts
08/19/1998CN1190888A Methods and compositions for inhibiting 5 'alpha'=reductase activity
08/19/1998CA2223020A1 Human protein kinase hoacf72
08/18/1998US5795915 Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reutake and new compounds for this use
08/18/1998US5795908 Fkbp immunophilins for enzyme inhibitors
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795903 Anticonvulsants, antianxiety, schizophrenia, sleep disorders, brain disorders and alzheimer's or parkinson's disease
08/18/1998US5795900 Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
08/18/1998US5795888 Analgesics, antiinflammatory agents, antidiabetic agents
08/18/1998US5795887 Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
08/18/1998US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795592 Calcium channel blocker
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2215920A1 Drug binding protein
08/18/1998CA2161768C 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
08/18/1998CA2085008C Calcium citrate malate composition
08/13/1998WO1998035061A2 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998WO1998035056A1 Identification of inhibitors of protein tyrosine kinase 2
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998035043A1 Human sdf-5 protein and compositions
08/13/1998WO1998035042A2 Activity dependent neurotrophic factor iii (adnf iii)
08/13/1998WO1998035039A1 Dendritic cell-derived growth factor
08/13/1998WO1998035036A1 Heregulin variants
08/13/1998WO1998035034A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998WO1998035020A2 Methods for modulating hematopoiesis and vascular growth
08/13/1998WO1998034959A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
08/13/1998WO1998034957A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE α-GALACTOSYL EPITOPE
08/13/1998WO1998034954A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998WO1998034952A2 Il-2 gene expression and delivery systems and uses
08/13/1998WO1998034942A2 Dinucleotides and their use
08/13/1998WO1998034935A1 Fibrinogen receptor antagonist prodrugs
08/13/1998WO1998034929A1 Il-8 receptor antagonists
08/13/1998WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/13/1998WO1998034915A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
08/13/1998WO1998034910A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/13/1998WO1998034644A1 Compositions and articles for reducing the effects of inflammation
08/13/1998WO1998034643A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034631A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
08/13/1998WO1998034625A1 Substance and method for reduction of lipids and cholesterol
1 ... 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 ... 1564